Published on If you think legalizing marijuana won't affect you... Think Again. (http://rethinkpot.org)

Home > Two 24-Week Phase 3 Studies of Lumacaftor in Combination with Ivacaftor Met Primary Endpoint with Statistically Significant Improvements in Lung Function

Two 24-Week Phase 3 Studies of Lumacaftor in Combination with Ivacaftor Met Primary Endpoint with Statistically Significant Improvements in Lung Function

Link: 
Two 24-Week Phase 3 Studies of Lumacaftor in Combination with Ivacaftor Met Primary Endpoint with Statistically Significant Impr [1]
Article Date: 
Tuesday, June 24, 2014

Tags:

If you think legalizing marijuana won't affect you... Think Again.

Source URL: http://rethinkpot.org/two-24-week-phase-3-studies-lumacaftor-combination-ivacaftor-met-primary-endpoint-statistically

Links
[1] http://investors.vrtx.com/releasedetail.cfm?ReleaseID=856185
[2] http://rethinkpot.org/tags/cystic-fibrosis
[3] http://rethinkpot.org/tags/fda
[4] http://rethinkpot.org/tags/research